Search Results - "Reina Zoilo, Juan José"

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial by Aranda, Enrique, Viéitez, Jose Maria, Gómez-España, Auxiliadora, Gil Calle, Silvia, Salud-Salvia, Antonieta, Graña, Begoña, Garcia-Alfonso, Pilar, Rivera, Fernando, Quintero-Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González-Flores, Encarnación, Salgado Fernández, Mercedes, Guillén‑Ponce, Carmen, Garcia-Carbonero, Rocio, Safont, María José, La Casta Munoa, Adelaida, García-Paredes, Beatriz, López López, Rafael, Sastre, Javier, Díaz-Rubio, Eduardo

“…Purpose5-Fluorouracil/leucovorin, oxaliplatin, irinotecan (FOLFOXIRI) plus bevacizumab is more effective than doublets plus bevacizumab as first-line therapy…”
Get full text

Immune Microenvironment in Colorectal Cancer : A New Hallmark to Change Old Paradigms by Henao Carrasco, Fernando, Nogales Fernández, Esteban, de la Cruz-Merino, Luis, Pulido, Enrique Grande, Codes Manuel de Villena, Manuel, Reina Zoilo, Juan José, Vicente Baz, David

“…Impact of immune microenvironment in prognosis of solid tumors has been extensively studied in the last few years. Specifically in colorectal carcinoma,…”
Get full text

Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study by López Muñoz, Ana María, González Flores, Encarnación, Carral Maseda, Alberto, Pimentel Cáceres, Paola, Afonso Gómez, Ruth, López López, Carlos, Jimeno Maté, Raquel, Reina Zoilo, Juan José, Castañón López, Carmen, Salgado Fernández, Mercedes, Aparicio Urtasun, Jorge, Asensio Martínez, Elena, Martín Gómez, Teresa

“…To describe the dosing patterns of regorafenib in a real-world population of patients with metastatic colorectal cancer (mCRC) in a routine clinical practice…”
Get full text

Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain by Garcia-Carbonero, Rocio, González Astorga, Beatriz, Vidal Tocino, Rosario, Contreras Toledo, Débora, Pericay, Carles, Fernández Montes, Ana, Falcó, Esther, González Cordero, Marta, Reina Zoilo, Juan José, Alonso, Vicente, Rodríguez Salas, Nuria, Gil-Raga, Mireia, Santos, Cristina, Páez, David, Anton-Pascual, Beatriz, Aguilar, Fernando, Morales, Pilar

“…Purpose Clinical practice guidelines recommend that all patients with metastatic colorectal cancer (mCRC) should be tested for mismatch repair deficiency…”
Get full text

Delphi consensus on the follow-up of cancer patients with breakthrough pain under opioid treatment by Gonzalez Larriba, Jose Luis, Cayuela, Diego, Fernandez Calvo, Ovidio, Garcera, Salvador, Molina, Raquel, Reina-Zoilo, Juan José, Guillem, Vicente, Camps, Carlos, Feyjoo, Margarita

“…Abstract only e23135 Background: Breakthrough cancer pain (BTcP) is one of the most common symptoms related with the disease and its treatment. Its management…”
Get full text

Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs) by Aranda, Enrique, Garcia-Alfonso, Pilar, Vieitez, Jose María, Ortiz, Maria Jose, López-López, Carlos, Reina-Zoilo, Juan José, Salud Salvia, Antonieta, Quintero Aldana, Guillermo Alfonso, Robles, Luis, Safont, Maria Jose, La Casta Munoa, Adelaida, Alés, Inmaculada, Polo Marques, Eduardo, Gallego Plazas, Javier, García de Paredes, Beatriz, Lopez, Rafael, Mónica, Guillot, Valladares-Ayerbes, Manuel, Sastre, Javier, Díaz-Rubio, Eduardo

“…Abstract only 3549 Background: The outcome for mCRC has changed since the introduction of new chemotherapy schedules and targeted therapies, however new…”
Get full text

Randomized phase III study comparing FOLFOX + bevacizumab versus folfoxiri + bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs) by Sastre, Javier, Vieitez, Jose María, Gomez-España, Maria Auxilidora, Gil Calle, Silvia, Salud Salvia, Antonieta, Suárez, Begoña Graña, Garcia-Alfonso, Pilar, Martinez de Castro, Eva, Quintero Aldana, Guillermo Alfonso, Reina-Zoilo, Juan José, González Flores, Encarnación, Fernández, Mercedes Salgado, Guillen, Carmen, Garcia-Carbonero, Rocio, Safont, Maria Jose, La Casta Munoa, Adelaida, García de Paredes, Beatriz, Lopez, Rafael, Aranda, Enrique, Díaz-Rubio, Eduardo

“…Abstract only 3507 Background: FOLFOXIRI+BEV has demonstrated a survival benefit compared with FOLFIRI plus BEV (TRIBE Lancet Oncol 2015) in first-line mCRC…”
Get full text

Delphi Consensus on the Follow-up of Cancer Patients with Breakthrough Pain Under Opioid Treatment by Larriba González, José Luis, Cayuela López, Diego, Fernández Calvo, Ovidio, Garcerá Juan, Salvador, Molina Villaverde, Raquel, Reina Zoilo, Juan José, Guillém, Vicente, Camps, Carlos, Feyjóo, Margarita

“…Background Breakthrough cancer pain (BTcP) is one of the most common symptoms related to the disease and its treatment. Its management differs from that of…”
Get full text

Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms by Pulido, Enrique Grande, Reina Zoilo, Juan José, Nogales Fernández, Esteban, Vicente Baz, David, Henao Carrasco, Fernando, de la Cruz-Merino, Luis, Codes Manuel de Villena, Manuel

“…Impact of immune microenvironment in prognosis of solid tumors has been extensively studied in the last few years. Specifically in colorectal carcinoma,…”
Get full text

Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with advanced pancreatic adenocarcinoma (NCT03665441) by Hammel, Pascal, El-Hariry, Iman, Macarulla, Teresa, Garcia-Carbonero, Rocio, Metges, Jean-Philippe, Bouché, Olivier, Portales, Fabienne, Pazo Cid, Roberto A., Mineur, Laurent, Cubillo Gracian, Antonio Manuel, Trouilloud, Isabelle, Guimbaud, Rosine, Tougeron, David, Reina Zoilo, Juan Jose, Feliu, Jaime, Sauri, Tamara, Fountzilas, Christos, Kay, Richard, Youssoufian, Hagop, Hidalgo, Manuel

“…Abstract only 518 Background: Eryaspase, asparaginase encapsulated in red blood cells is an investigational product under development. The encapsulated…”
Get full text